Subjects: Pharmaceutical Science >> Medicinal Chemistry submitted time 2024-12-30
Gao, Cheng-Long
Song, Jin-Qian
Yang, Ze-Nan
Wang, Haojie
Wu, Xin-Yuan
Shao, Changwei
Dai, Hong-Xia
Chen, Kaixian
Guo, Yue-Wei
Pang, Tao
Li, Xu-Wen
Abstract： Acute lung injury is a devastating illness characterized by severe inflammation mediated by aberrant activation of macrophages, resulting in significant morbidity and mortality, highlighting the urgent need for novel pharmacological targets and drug candidates. In this study, we identified a novel target for regulating inflammation in macrophages and acute lung injury via chemical proteomics and genetics based on a marine alkaloid, naamidine J (NJ). The structures of NJ-related naamidine alkaloids were first confirmed or revised by a combination of quantum chemical calculations and X-ray diffraction analysis. NJ was found as a potential anti-inflammatory agent by screening our compound library, and CSE1L was identified by chemoproteomics as a main cellular target of NJ to inhibit inflammation in macrophages and protect against acute lung injury. Mechanistically, we demonstrated that NJ directly interacted with CSE1L on the sites of His745 and Phe903 and then inhibited the nuclear translocation and tran
Hits
YES
Hits
Downloads
Comment